期刊文献+

常见肾脏疾病尿电导率的探讨分析 被引量:5

Analysis of Urine Conductivity in Common Kidney Disease
在线阅读 下载PDF
导出
摘要 探讨分析常见肾脏疾病尿电导率的改变及应用。用Sysmex公司的全自动尿中有形成分分析仪uf-1000i(简称uf-1000i)检测1553名健康人员和1176名肾脏病人的尿液,对尿电导率的结果进行分析。其中肾脏病人分为四组,分别是肾病综合征组、慢性肾炎组、急性肾衰组和隐匿性肾小球肾炎组。肾病综合征组、慢性肾炎组、急性肾衰组和隐匿性肾小球肾炎组尿电导率较健康对照组明显降低,差异具有统计学意义(P<0.01);肾病综合征组、慢性肾炎组和急性肾衰组尿电导率明显低于隐匿性肾小球肾炎组,差异具有统计学意义(P<0.01)。尿电导率可以作为肾脏功能和尿液浓缩功能好坏的重要参考指标。 To analyze the change and application of urine conductivity in common kidney disease,the urine samples of 1553 healthy people and 1176 kidney diseases patients was analyzed by Sysmex automatic urine elements analyzer uf-1000i(shorten form uf-1000i) and German Roche urisys 2400 dry chemical urine analyzer.The kidney patients were divided into nephrotic syndrome,chronic nephritis,acute renal failure and latent glomerulonephritis groups.The results showed that the urine conductivity in all kidney diseases patients was significant lower than that of health control(P0.01).The urine conductivity in patients with nephrotic syndrome,chronic nephritis,acute renal failure were significant lower than the patients in latent glomerulonephritis(P0.01).The urine conductivity may serve as an important index in evaluating the kidney function and urine concentration.
作者 孙子涵
出处 《标记免疫分析与临床》 CAS 2010年第4期262-263,共2页 Labeled Immunoassays and Clinical Medicine
关键词 肾脏疾病 尿电导率 uf-1000i Kidney disease Urine conductivity uf-1000i
  • 相关文献

参考文献4

二级参考文献24

  • 1张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. 被引量:69
  • 2Xue JL,Ma JZ,Louis TA,et al.Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.J Am Soc Nephrol,2001,12:2753-2758.
  • 3Coresh J,Astor BC,Green T,et al.Prevalence of Chronic Kidney Disease and Decreased Kidney Function in the Adult US Population:Third National Health and Nutrition Examination Survey.Am J Kidney Dis,2003,41:1-12.
  • 4Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on prevention,detection,evaluation and treatment of high blood pressure.JAMA,2003,21:2560-2572.
  • 5Anonymous.KDOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Kidney Disease Outcome Quality Initiative.Am J Kidney Dis,2002,39 Suppl 2:S1-S246.
  • 6Chadban SJ,Briganti EM,Kerr PG,et al.Prevalence of kidney damage in Australian adults:the AusDiab kidney study.J Am Soc Nephrol,2003,14:S131-S138.
  • 7Garg AX,Kiberd BA,Clark WF,et al.Albuminuria and renal insufficiency prevalence guides population screening:results form the NHANESⅢ.Kidney Int,2002,61:2165-2175.
  • 8Ramirez SP,Mcclellan W,Port FK,et al.Risk factors for proteinuria in a large,multiracial,southeast Asian population.J Am Soc Nephrol,2002,13:1907-1917.
  • 9Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO).Kidney Int,2005,67:2089-2100.
  • 10Zuo L,Ma YCH,Wang M,et al.Application of glomerular giltration rate estimating euqtions in Chinese patients with chronic kidney disease.Am J Kidney Dis,2005,45:463-472.

共引文献378

同被引文献35

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部